ArticleCureus2025
Tumor-to-Tumor Metastasis in a Patient With Hemangioblastoma Unrelated to von Hippel-Lindau Disease: A Case Report and Review of the Literature.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tumor-to-tumor metastasis (TTM) is a rare phenomenon in which one malignant tumor ("donor") metastasizes to another benign tumor ("recipient"). In the central nervous system (CNS), meningioma is considered one of the most frequent recipients, while hemangioblastoma (HGB) has also been reported, typically in association with von Hippel-Lindau (VHL) disease. A 61-year-old woman with a history of bilateral breast cancer treated 17 years earlier presented with right-sided ataxic hemiparesis. Magnetic resonance imaging revealed a gadolinium-enhanced mass in the right cerebellum, initially diagnosed as a metastatic brain tumor. Despite stereotactic radiotherapy, symptoms persisted and the lesion enlarged. Surgical resection was performed via the occipital trans-tentorial approach. Intraoperative findings revealed a reddish, vascular tumor with a xanthochromic area. Complete resection was achieved. Pathological examination confirmed two distinct components: HGB and metastatic breast carcinoma, establishing the diagnosis of TTM. No evidence of VHL was identified. The pathogenesis of TTM remains unclear, although factors such as recipient tumor vascularity and a favorable microenvironment are proposed. The rarity of non-VHL-associated TTM in HGB emphasizes the need for further case accumulation, to clarify the underlying mechanisms. We report the first description of TTM involving metastatic breast cancer to a sporadic HGB in the CNS, unrelated to VHL. This case highlights the importance of considering TTM among the differential diagnoses for CNS tumors, even in the absence of VHL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.